相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study
Alicia Gilsenan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services
W. F. Lems et al.
OSTEOPOROSIS INTERNATIONAL (2021)
Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review
Sean J. Iwamoto et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2021)
Teriparatide: Label changes and identifying patients for long-term use
Paul D. Miller et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2021)
Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa
L. Seefried et al.
OSTEOPOROSIS INTERNATIONAL (2021)
Combination of DXA and BIS Predicts Jump Power Better Than Traditional Measures of Sarcopenia
Benjamin Rush et al.
JBMR PLUS (2021)
Proceedings of the 2019 Santa Fe Bone Symposium: New Concepts in the Care of Osteoporosis and Rare Bone Diseases
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2020)
Artificial Intelligence in Musculoskeletal Imaging: A Paradigm Shift
Chantal M. Wiepjes et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia
Michael P. Whyte et al.
BONE (2020)
Diet and Physical Activity Behaviors Among Adolescent Transgender Students: School Survey Results
Anna Bishop et al.
JOURNAL OF ADOLESCENT HEALTH (2020)
Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society
Denise M. van de Laarschot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
Dolores Shoback et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS—2020 UPDATE
Pauline M. Camacho et al.
Endocrine Practice (2020)
T-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial
Felicia Cosman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
COVID-19, Medical Education, and Bone Health: Insights From Project ECHO
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2020)
Targeted vertebral fracture assessment for optimizing fracture prevention in Canada
William D. Leslie et al.
ARCHIVES OF OSTEOPOROSIS (2020)
Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab
S. R. Cummings et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials
Dennis M Black et al.
Lancet Diabetes & Endocrinology (2020)
The Rare Bone Disease TeleECHO Program: Leveraging Telehealth to Improve Rare Bone Disease Care
Laura L. Tosi et al.
CURRENT OSTEOPOROSIS REPORTS (2020)
Burden of Illness in Adults With Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry
Lothar Seefried et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Preoperative bone health assessment and optimization in spine surgery
Paul A. Anderson et al.
NEUROSURGICAL FOCUS (2020)
Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones
Sebastian E. E. Schagen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Periprosthetic fractures: the next fragility fracture epidemic? A national observational study
Alex Bottle et al.
BMJ OPEN (2020)
Proceedings of the 2018 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2019)
Osteoporosis Is Common and Undertreated Prior to Total Joint Arthroplasty
James T. Bernatz et al.
JOURNAL OF ARTHROPLASTY (2019)
Treated Osteoporosis Is Still Osteoporosis
E. Michael Lewiecki et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Relationship Between Bone Mineral Density T-Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment
S. Ferrari et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
Richard Eastell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Treat-to-target in rheumatoid arthritis - are we there yet?
Ronald van Vollenhoven
NATURE REVIEWS RHEUMATOLOGY (2019)
Project ECHO Telehealth to Expand Capacity to Deliver Best Practice Medical Care
E. Michael Lewiecki et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2019)
Changes in femoral bone mineral density after total knee arthroplasty: a systematic review and meta-analysis
Joel M. Prince et al.
ARCHIVES OF OSTEOPOROSIS (2019)
Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for Osteoporosis
E. Michael Lewiecki et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Rates of Total Joint Replacement in the United States: Future Projections to 2020-2040 Using the National Inpatient Sample
Jasvinder A. Singh et al.
JOURNAL OF RHEUMATOLOGY (2019)
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
Erik A. Imel et al.
LANCET (2019)
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Dieter Haffner et al.
NATURE REVIEWS NEPHROLOGY (2019)
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
Anthony A. Portale et al.
CALCIFIED TISSUE INTERNATIONAL (2019)
Detection of Atypical Femur Fractures
Angela M. Cheung et al.
JOURNAL OF CLINICAL DENSITOMETRY (2019)
Bone Densitometry in Transgender and Gender Non-Conforming (TGNC) Individuals: 2019 ISCD Official Position
Harold N. Rosen et al.
JOURNAL OF CLINICAL DENSITOMETRY (2019)
Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics
Christopher R. Shuhart et al.
JOURNAL OF CLINICAL DENSITOMETRY (2019)
Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group
J. P. Bilezikian et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial
John P. Bilezikian et al.
CURRENT MEDICAL RESEARCH AND OPINION (2019)
Bone Health Optimization: Beyond Own the Bone AOA Critical Issues
Paul A. Anderson et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2019)
Use of Bone Health Evaluation in Orthopedic Surgery: 2019 ISCD Official Position
Paul A. Anderson et al.
JOURNAL OF CLINICAL DENSITOMETRY (2019)
Lessons learned with Bone Health TeleECHO: making treatment decisions when guidelines conflict
M. S. Rothman et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Bone Health TeleECHO: a Force Multiplier to Improve the Care of Skeletal Diseases in Underserved Communities
E. Michael Lewiecki et al.
CURRENT OSTEOPOROSIS REPORTS (2019)
Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen
Chantal M. Wiepjes et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study
E. Michael Lewiecki et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Bone Health in the Transgender Population
Micol S. Rothman et al.
CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM (2019)
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
Steven R. Cummings et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur
S. L. Greenspan et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2018)
Hydroxyvitamin D assays: An historical perspective from DEQAS
G. D. Carter et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
Primary Hyperparathyroidism
John P. Bilezikian
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Surgical Management of Atypical Femur Fractures Associated With Bisphosphonate Therapy
Michael Githens et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2018)
Combination of DXA and BIS body composition measurements is highly correlated with physical function-an approach to improve muscle mass assessment
Adam J. Kuchnia et al.
ARCHIVES OF OSTEOPOROSIS (2018)
Primary Care Clinicians' Willingness to Care for Transgender Patients
Deirdre A. Shires et al.
ANNALS OF FAMILY MEDICINE (2018)
IT'S TIME TO STOP PRESCRIBING ERGOCALCIFEROL
Neil C. Binkley et al.
ENDOCRINE PRACTICE (2018)
Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis
Steven R. Cummings et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Telementoring: a novel approach to reducing the osteoporosis treatment gap
E. M. Lewiecki et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Responses to Treatment With Teriparatide in Patients With Atypical Femur Fractures Previously Treated With Bisphosphonates
Nelson B. Watts et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Total Body Less Head Measurement Is Most Appropriate for Lean Mass Assessment in Adults
Diane Krueger et al.
JOURNAL OF CLINICAL DENSITOMETRY (2017)
Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2017)
Effect of Sex Steroids on the Bone Health of Transgender Individuals: A Systematic Review and Meta-Analysis
Naykky Singh-Ospina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline
Wylie C. Hembree et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Comparative analysis of nutritional guidelines for vitamin D
Roger Bouillon
NATURE REVIEWS ENDOCRINOLOGY (2017)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention
Michael F. Holick
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2017)
Leveraging Scarce Resources With Bone Health TeleECHO to Improve the Care of Osteoporosis
E. Michael Lewiecki et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2017)
Hypophosphatasia: An overview For 2017
Michael P. Whyte
BONE (2017)
A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX
Eugene V. McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
The vitamin D status of the US population from 1988 to 2010 using standardized serum concentrations of 25-hydroxyvitamin D shows recent modest increases
Rosemary L. Schleicher et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
Hypophosphatasia and the risk of atypical femur fractures: a case-control study
Timothy Bhattacharyya et al.
BMC MUSCULOSKELETAL DISORDERS (2016)
Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling
Gary Hattersley et al.
ENDOCRINOLOGY (2016)
How do bisphosphonates affect fracture healing?
Stephen L. Kates et al.
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2016)
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis A Randomized Clinical Trial
Paul D. Miller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
Robert A. Adler et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Proceedings of the 2015 Santa Fe Bone Symposium: Clinical Applications of Scientific Advances in Osteoporosis and Metabolic Bone Disease
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2016)
Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia
Michael P. Whyte et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cancel the denosumab holiday
M. R. McClung
OSTEOPOROSIS INTERNATIONAL (2016)
Effectiveness of Teriparatide on Fracture Healing: A Systematic Review and Meta Analysis
Zhongju Shi et al.
PLOS ONE (2016)
The Importance of Bone Mineral Density in Hip Arthroplasty: Results of a Survey Asking Orthopaedic Surgeons about Their Opinions and Attitudes Concerning Osteoporosis and Hip Arthroplasty
Gerrit Steffen Maier et al.
ADVANCES IN ORTHOPEDICS (2016)
Vitamin D, calcium homeostasis and aging
Vaishali Veldurthy et al.
BONE RESEARCH (2016)
Asfotase alfa therapy for children with hypophosphatasia
Michael P. Whyte et al.
JCI INSIGHT (2016)
Adjusting Fracture Probability by Trabecular Bone Score
Eugene V. McCloskey et al.
CALCIFIED TISSUE INTERNATIONAL (2015)
Update on osteoporosis from the 2014 Santa Fe Bone symposium
E. Michael Lewiecki et al.
ENDOCRINE RESEARCH (2015)
Incidence and predisposing factors of periprosthetic proximal femoral fractures: a literature review
Claudia C. Sidler-Maier et al.
INTERNATIONAL ORTHOPAEDICS (2015)
Does serum 25-hydroxyvitamin D decrease during acute-phase response? A systematic review
Mariana Costa Silva et al.
NUTRITION RESEARCH (2015)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Osteoporosis Update: Proceedings of the 2013 Santa Fe Bone Symposium
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2014)
Guidelines for optimizing design and analysis of clinical studies of nutrient effects
Robert P. Heaney
NUTRITION REVIEWS (2014)
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
E. S. Siris et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Osteoporosis Update From the 2012 Santa Fe Bone Symposium
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2013)
The Role of the Parent Compound Vitamin D with Respect to Metabolism and Function: Why Clinical Dose Intervals Can Affect Clinical Outcomes
Bruce W. Hollis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures
Matthew Austin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Proceedings of the 2011 Santa Fe Bone Symposium
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2012)
Osteoporosis Update From the 2010 Santa Fe Bone Symposium
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2011)
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
A. Catharine Ross et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Periprosthetic Fractures: Epidemiology and Future Projections
Gregory J. Della Rocca et al.
JOURNAL OF ORTHOPAEDIC TRAUMA (2011)
Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
Sanjeev Arora et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
2009 Santa Fe Bone Symposium
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2010)
Extracellular Water May Mask Actual Muscle Atrophy During Aging
Yosuke Yamada et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2010)
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
2008 Santa Fe Bone Symposium: Update on Osteoporosis
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2009)
Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3–4, 2007
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2008)
Routine versus targeted vertebral fracture assessment for the detection of vertebral fractures
E. T. Middleton et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Low vitamin D status despite abundant sun exposure
N. Binkley et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Denosumab in postmenopausal women with low bone mineral density
MR McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D
BW Hollis
JOURNAL OF NUTRITION (2005)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
